Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mullerian inhibiting substance: an update.

David T MacLaughlin1, Patricia K Donahoe

  • 1Pediatric Surgical Research Laboratories, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Advances in Experimental Medicine and Biology
|February 11, 2003
PubMed
Summary

Mullerian Inhibiting Substance (MIS) research, driven by pediatric specialists, improves understanding of reproductive tract development and intersex conditions. This knowledge aids in diagnosing and managing related disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling patient variants of <i>Cnot1</i> and <i>Cdc42bpb</i> results in distinct forms of congenital diaphragmatic hernia in mice.

bioRxiv : the preprint server for biology·2026
Same author

Failure of endocytic flux in Donnai-Barrow syndrome caused by LRP2 p.C1400R.

JCI insight·2026
Same author

Proximity Labeling Reveals How Lrp2 Interacts with the Endocytic Machine.

Journal of proteome research·2026
Same author

Histone methylation activity of KMT2D is required for proliferative control of the developing lung.

bioRxiv : the preprint server for biology·2026
Same author

Gene therapy delivery of anti-Müllerian hormone in prepubertal female domestic cats induces long-term sterilization.

Nature communications·2025
Same author

Anti-Müllerian hormone ameliorates uterine DNA damage response and prevents pregnancy complications in doxorubicin-treated mice†.

Biology of reproduction·2025

Area of Science:

  • Reproductive biology
  • Developmental endocrinology
  • Molecular genetics

Background:

  • Decades of research into Mullerian Inhibiting Substance (MIS) have been motivated by clinical needs in pediatric surgery and endocrinology.
  • Understanding the molecular pathophysiology of genital tract defects is crucial for patient care.

Purpose of the Study:

  • To elucidate the role of MIS in normal reproductive tract development in both sexes.
  • To translate bench research into clinical applications for diagnosing and managing intersex conditions.
  • To explore the clinical utility of MIS research in pediatric endocrinology.

Main Methods:

  • Molecular analyses of Mullerian Inhibiting Substance (MIS) and its receptor gene mutations.
  • Investigation of persistent Mullerian duct syndrome.

Related Experiment Videos

  • Development and application of MIS enzyme-linked immunosorbent assays (ELISAs).

    • Main Results:

    • Identified key genes involved in reproductive tract development.
    • Developed diagnostic tools like MIS ELISAs for assessing testicular function.
    • Advanced the understanding of persistent Mullerian duct syndrome.
    • Provided insights into monitoring gonadal tumor progression.

    Conclusions:

    • Continued molecular investigation of MIS and its receptor is vital for advancing reproductive medicine.
    • Translational research in this area offers significant potential for improved clinical diagnosis and management of intersex patients.
    • MIS research has yielded practical applications, including diagnostic assays and tumor monitoring tools.